Benzinga · Sep 13, 2022
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
InMed Pharmaceuticals Inc. (NASDAQ: INM) gained 70.4% to close at $18.78 after the company on Friday announced a $6 million private placement priced at $8.68 per share.
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares surged 65% to close at $38.11 on Monday after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
PolyPid Ltd. (NASDAQ: PYPD) gained 58.3% to close at $1.71. The company earlier announced it will present Phase 2 D-PLEX₁₀₀ data at the European Society for Coloproctology Scientific Conference next week.
Arqit Quantum Inc. (NASDAQ: ARQQ) shares gained 38.1% to close at $7.72. The company will present at the H.C. Wainwright 24th Annual Global Investment Conference later today.
PaxMedica, Inc. (NASDAQ: PXMD) rose 36.6% to settle at $4.33 after TardiMed Sciences' Michael Derby on Friday disclosed a 63.4% active stake in the company.
Allego N.V. (NYSE: ALLG) jumped 33.5% to close at $5.90.
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) jumped 30.7% to close at $12.09. IDEAYA Biosciences disclosed interim Phase 2 clinical results for darovasertib and crizotinib synthetic lethal combination in metastatic uveal melanoma.
Clovis Oncology, Inc. (NASDAQ: CLVS) climbed 30.4% to close at $1.50 after the company said Rubraca (Rucaparib) as first-line maintenance treatment improves progression-free survival in women with advanced ovarian cancer across disease risk subgroups.
Annovis Bio, Inc. (NYSE: ANVS) gained 29.5% to settle at $19.82 on above-average volume.
Kaspien Holdings Inc. (NASDAQ: KSPN) surged 27.7% to close at $2.86.
IHS Holding Limited (NYSE: IHS) jumped 24.9% to close at $7.83. IHS Holding, last month, said Q2 EPS results down year-over-year.
Gogoro Inc. (NASDAQ: GGR) gained 21.3% to close at $5.25. Gogoro recently launched its battery-swapping system and Smart scooters in the Tel Aviv metropolitan area.
ImmunityBio, Inc. (NASDAQ: IBRX) jumped 20.9% to close at $5.61.
POINT Biopharma Global Inc. (NASDAQ: PNT) rose 19.8% to close at $10.27 after the company published a poster at ESMO Congress 2022 highlighting updated safety and efficacy data from its Phase 3 SPLASH trial of PNT2002 in metastatic castration-resistant prostate cancer.
Rackspace Technology, Inc. (NASDAQ: RXT) gained 18.8% to settle at $6.32.
Magic Empire Global Limited (NASDAQ: MEGL) jumped 17.9% to close at $6.00.
Regulus Therapeutics Inc. (NASDAQ: RGLS) rose 16.9% to close at $1.94 after the company announced topline safety and PK data from its Phase 1 SAD clinical trial of RGLS8429. The study demonstrated that RGLS8429 has a favorable safety and PK profile.
TuanChe Limited (NASDAQ: TC) gained 16.8% to close at $3.20.
Asana, Inc. (NYSE: ASAN) climbed 16.4% to close ...
Benzinga · Sep 12, 2022
Gainers
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) gained 69% to $0.4664 after the company announced a 1-for-30 reverse stock split.
Arqit Quantum Inc. (NASDAQ: ARQQ) shares climbed 34.7% to $7.53. The company will present at the H.C. Wainwright 24th Annual Global Investment Conference later today.
InMed Pharmaceuticals Inc. (NASDAQ: INM) gained 32.5% to $14.60 after the company on Friday announced a $6 million private placement priced at $8.68 per share.
Ra Medical Systems, Inc. (NYSE: RMED) surged 28% to $0.1865 after the company announced a merger agreement with Catheter Precision. Catheter Precision will become a wholly owned subsidiary of Ra Medical.
Vinco Ventures, Inc. (NASDAQ: BBIG) gained 25% to $1.2500.
IHS Holding Limited (NYSE: IHS) jumped 19.2% to $7.47. IHS Holding, last month, said Q2 EPS results down year-over-year.
Gogoro Inc. (NASDAQ: GGR) gained 19.1% to $5.16. Gogoro recently launched its battery-swapping system and Smart scooters in the Tel Aviv metropolitan area.
Ribbon Communications Inc. (NASDAQ: RBBN) rose 19% to $3.8450.
Allego N.V. (NYSE: ALLG) gained 18.3% to $5.23.
Regulus Therapeutics Inc. (NASDAQ: RGLS) gained 16.8% to $1.94 after the company announced topline safety and PK data from its Phase 1 SAD clinical trial of RGLS8429. The study demonstrated that RGLS8429 has a favorable safety and PK profile.
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) surged 15.6% to $10.70. IDEAYA Biosciences disclosed interim Phase 2 clinical results for darovasertib and crizotinib synthetic lethal combination in metastatic uveal melanoma.
Carvana Co. (NYSE: CVNA) rose 13.7% to $41.64. Piper Sandler upgraded Carvana from Neutral to Overweight and lowered the price target from $98 to $73.
POINT Biopharma Global Inc. (NASDAQ: PNT) gained 13.4% to $9.72 after the company published a poster at ESMO Congress 2022 highlighting updated safety ...
Benzinga · Sep 8, 2022
Gainers
IMARA Inc. (NASDAQ: IMRA) jumped 74.8% to settle at $2.01 on Wednesday after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront.
Azure Power Global Limited (NYSE: AZRE) shares jumped 35.4% to close at $4.86. Azure Power Global recently announced the resignation of Harsh Shah as CEO.
SelectQuote, Inc. (NYSE: SLQT) rose 28.8% to close at $1.43.
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) gained 27.7% to close at $36.40 amid post-IPO volatility.
Spero Therapeutics, Inc. (NASDAQ: SPRO) shares jumped 26.6% to close at $1.43. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.
a.k.a. Brands Holding Corp. (NYSE: AKA) gained 23.7% to settle at $2.92 amid overall market strength as stocks rebound from recent weakness.
Pingtan Marine Enterprise Ltd. (NASDAQ: PME) climbed 23.3% to close at $0.8998.
Nutex Health, Inc. (NASDAQ: NUTX) gained 21.9% to close at $3.17.
Molecular Templates, Inc. (NASDAQ: MTEM) rose 21.8% to close at $0.83. Molecular Templates said on August 31, it received notice from Nasdaq that the company no longer meets minimum bid price requirement.
Reata Pharmaceuticals, Inc. (NASDAQ: RETA) jumped 21.1% to settle at $27.07.
Amyris, Inc. (NASDAQ: AMRS) gained 19.6% to settle at $3.24.
Latch, Inc. (NASDAQ: LTCH) jumped 19.2% to close at $1.24.
Tupperware Brands Corporation (NYSE: TUP) gained 19.2% to settle at $8.77 amid overall market strength as stocks rebound from recent weakness.
Vicarious Surgical Inc. (NASDAQ: RBOT) rose 18.8% to close at $4.37. Vicarious Surgical, last month, posted a Q2 loss of $0.16 per share.
Biophytis S.A. (NASDAQ: BPTS) shares gained 18.1% to close at $1.11 after the company released topline results from its phase 2-3 COVA study evaluating Sarconeos (BIO101) in treating COVID-19-related respiratory failure.
Glaukos Corporation (NYSE: GKOS) climbed 18.5% to close at $57.01 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary efficacy endpoints through 3 months in both Phase 3 trials and demonstrated excellent tolerability and a ...
Benzinga · Sep 7, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones adding around 450 points on Wednesday.
The Dow traded up 1.45% to 31,596.87 while the NASDAQ rose 1.99% to 11,774.77. The S&P 500 also rose, gaining, 1.74% to 3,976.30.
Also check this: Fear & Greed Index Remains In 'Fear' Zone As US Stocks Drop
Leading and Lagging Sectors
Utilities shares jumped by 2.6% on Tuesday. Meanwhile, top gainers in the sector included Azure Power Global Limited (NYSE: AZRE), up 32% and Sunnova Energy International Inc. (NYSE: NOVA) up 10%.
In trading on Tuesday, energy shares fell by 1.5%.
Top Headline
The trade deficit narrowed by $10.2 billion to a nine-month low level of $70.7 billion in July. Exports from the US rose by 0.2% from the prior month to $259.3 billion, while imports fell 2.9% to $329.9 billion.
Equities Trading UP
Glaukos Corporation (NYSE: GKOS) shares shot up 25% to $60.29 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary efficacy endpoints through 3 months in both Phase 3 trials and demonstrated excellent tolerability and a favorable safety ...
